speb/financial-data huggingface dataset:
ZKH cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -16405000.00
ZKH income_statement (annual, 2025-12-31) — Net Income: -139742000.00
ZKH income_statement (quarterly, 2025-12-31) — Net Income: 4797000.00
ZKH income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -139742000.00
ZKH income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 4797000.00
ZKH income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -139742000.00
ZKH income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 4797000.00
ZKH income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -139742000.00
ZKH income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 4797000.00
ZKH income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -139742000.00
ZKH income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 4797000.00
ZKH cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -139742000.00
ZKH income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -139742000.00
ZKH income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 4797000.00
ZKH cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -665000.00
ZKH income_statement (annual, 2025-12-31) — Net Interest Income: 38738000.00
ZKH income_statement (quarterly, 2025-12-31) — Net Interest Income: 8783000.00
ZKH cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -274460000.00
ZKH cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -65928000.00
ZKH cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 5072000.00
ZKH income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 38738000.00
ZKH income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 8783000.00
ZKH balance_sheet (annual, 2025-12-31) — Net PPE: 328390000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Net PPE: 328390000.00
ZKH cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -49348000.00
ZKH cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -71000000.00
ZKH balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 2878073000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 2878073000.00
ZKH income_statement (annual, 2025-12-31) — Normalized EBITDA: -79347000.00
ZKH income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 7901000.00
ZKH income_statement (annual, 2025-12-31) — Normalized Income: -139742000.00
ZKH income_statement (quarterly, 2025-12-31) — Normalized Income: 4797000.00
ZKH balance_sheet (annual, 2025-12-31) — Notes Receivable: 113291000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Notes Receivable: 113291000.00
ZKH cash_flow (annual, 2025-12-31) — Operating Cash Flow: 8789000.00
ZKH cash_flow (annual, 2025-12-31) — Operating Gains Losses: -37051000.00
ZKH income_statement (annual, 2025-12-31) — Operating Income: -213337000.00
ZKH income_statement (quarterly, 2025-12-31) — Operating Income: -28229000.00
ZKH income_statement (annual, 2025-12-31) — Operating Revenue: 8938015000.00
ZKH income_statement (quarterly, 2025-12-31) — Operating Revenue: 2543594000.00
ZKH balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 5563528436.00
ZKH balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 5563528436.00
ZKH balance_sheet (annual, 2025-12-31) — Other Current Assets: 25898000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 25898000.00
ZKH balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 2305000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 2305000.00
ZKH balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 149646000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 149646000.00
ZKH balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -30722000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -30722000.00
ZKH income_statement (annual, 2025-12-31) — Other Gand A: 576269000.00
ZKH income_statement (quarterly, 2025-12-31) — Other Gand A: 139916000.00
ZKH income_statement (annual, 2025-12-31) — Other Income Expense: 35546000.00
ZKH income_statement (quarterly, 2025-12-31) — Other Income Expense: 24730000.00
ZKH balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 32453000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 32453000.00
ZKH balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 28181000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 28181000.00
ZKH income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 35546000.00
ZKH income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 24730000.00
ZKH income_statement (annual, 2025-12-31) — Other Operating Expenses: 362173000.00
ZKH income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 87647000.00
ZKH balance_sheet (annual, 2025-12-31) — Other Properties: 247179000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Other Properties: 247179000.00
ZKH balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 825289000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 825289000.00
ZKH balance_sheet (annual, 2025-12-31) — Payables: 2740428000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Payables: 2740428000.00
ZKH balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 2740428000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 2740428000.00
ZKH balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 216057000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 216057000.00
ZKH balance_sheet (annual, 2025-12-31) — Prepaid Assets: 130509000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 130509000.00
ZKH income_statement (annual, 2025-12-31) — Pretax Income: -139053000.00
ZKH income_statement (quarterly, 2025-12-31) — Pretax Income: 5284000.00
ZKH cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 2460000.00
ZKH balance_sheet (annual, 2025-12-31) — Properties: 0.00
ZKH balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
ZKH cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 32868000.00
ZKH cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -665000.00
ZKH cash_flow (annual, 2025-12-31) — Purchase Of Investment: -488288000.00
ZKH cash_flow (annual, 2025-12-31) — Purchase Of PPE: -53043000.00
ZKH balance_sheet (annual, 2025-12-31) — Receivables: 3394234000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Receivables: 3394234000.00
ZKH income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 7512076000.00
ZKH income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 2160858000.00
ZKH income_statement (annual, 2025-12-31) — Reconciled Depreciation: 48356000.00
ZKH cash_flow (annual, 2025-12-31) — Repayment Of Debt: -660790000.00
ZKH cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -41001000.00
ZKH income_statement (annual, 2025-12-31) — Research And Development: 165518000.00
ZKH income_statement (quarterly, 2025-12-31) — Research And Development: 44095000.00
ZKH balance_sheet (annual, 2025-12-31) — Restricted Cash: 61871000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 61871000.00
ZKH balance_sheet (annual, 2025-12-31) — Retained Earnings: -5317131000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -5317131000.00
ZKH cash_flow (annual, 2025-12-31) — Sale Of Investment: 213828000.00
ZKH cash_flow (annual, 2025-12-31) — Sale Of PPE: 3695000.00
ZKH income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 585039000.00
ZKH income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 152951000.00
ZKH income_statement (annual, 2025-12-31) — Selling General And Administration: 1161308000.00
ZKH income_statement (quarterly, 2025-12-31) — Selling General And Administration: 292867000.00
ZKH balance_sheet (annual, 2025-12-31) — Share Issued: 5682357714.00
ZKH balance_sheet (quarterly, 2025-12-31) — Share Issued: 5682357714.00
ZKH cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 589790000.00
ZKH cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -660790000.00
ZKH cash_flow (annual, 2025-12-31) — Stock Based Compensation: 53817000.00
ZKH balance_sheet (annual, 2025-12-31) — Stockholders Equity: 2941333000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 2941333000.00
ZKH balance_sheet (annual, 2025-12-31) — Tangible Book Value: 2878073000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 2878073000.00
ZKH income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ZKH income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ZKH income_statement (annual, 2025-12-31) — Tax Provision: 689000.00
ZKH income_statement (quarterly, 2025-12-31) — Tax Provision: 487000.00
ZKH income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.25
ZKH income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.09
ZKH balance_sheet (annual, 2025-12-31) — Taxes Receivable: 23781000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 23781000.00
ZKH balance_sheet (annual, 2025-12-31) — Total Assets: 6529849000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Total Assets: 6529849000.00
ZKH balance_sheet (annual, 2025-12-31) — Total Capitalization: 2983984000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 2983984000.00
ZKH balance_sheet (annual, 2025-12-31) — Total Debt: 427052000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Total Debt: 427052000.00
ZKH balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 2941333000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 2941333000.00
ZKH income_statement (annual, 2025-12-31) — Total Expenses: 9201075000.00
ZKH income_statement (quarterly, 2025-12-31) — Total Expenses: 2585467000.00
ZKH balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 3588516000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 3588516000.00
ZKH balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 391650000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 391650000.00
ZKH balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 162726000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 162726000.00
ZKH income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -213337000.00
ZKH income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -28229000.00
ZKH balance_sheet (annual, 2025-12-31) — Total Tax Payable: 21487000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 21487000.00
ZKH balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 118829278.00
ZKH balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 118829278.00
ZKH balance_sheet (annual, 2025-12-31) — Treasury Stock: 81759000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 81759000.00
ZKH balance_sheet (annual, 2025-12-31) — Working Capital: 2712409000.00
ZKH balance_sheet (quarterly, 2025-12-31) — Working Capital: 2712409000.00
ZKH income_statement (quarterly, 2026-03-31) — +Operating Expense: 376524000.00
ZKH income_statement (quarterly, 2026-03-31) — +Total Revenue: 2113819000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 2487578000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 3078948000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 8385264000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -162340000.00
ZKH income_statement (quarterly, 2026-03-31) — Basic Average Shares: 161178753.00
ZKH income_statement (quarterly, 2026-03-31) — Basic EPS: 0.00
ZKH balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 130330000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Capital Stock: 4000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1074095000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1784549000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Common Stock: 4000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 2905739000.00
ZKH income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1759792000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 390097000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Current Assets: 5878927000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 47083000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Current Debt: 232305000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 279388000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 37805000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 37805000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 3194868000.00
ZKH income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 161178753.00
ZKH income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.00
ZKH income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -10103000.00
ZKH income_statement (quarterly, 2026-03-31) — EBIT: -7325000.00
ZKH income_statement (quarterly, 2026-03-31) — EBITDA: -7325000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -60860000.00
ZKH income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 131934000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Goodwill: 30807000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 68390000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 3241288000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Gross PPE: 314157000.00
ZKH income_statement (quarterly, 2026-03-31) — Gross Profit: 354027000.00
ZKH income_statement (quarterly, 2026-03-31) — Interest Expense: 2263000.00
ZKH income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 2263000.00
ZKH income_statement (quarterly, 2026-03-31) — Interest Income: 8407000.00
ZKH income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 8407000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Inventory: 642102000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Invested Capital: 3180695000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Line Of Credit: 230000000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 83247000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 42651000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 125898000.00
ZKH income_statement (quarterly, 2026-03-31) — Minority Interests: 0.00
ZKH income_statement (quarterly, 2026-03-31) — Net Income: -10103000.00
ZKH income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -10103000.00
ZKH income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -10103000.00
ZKH income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -10103000.00
ZKH income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -10103000.00
ZKH income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -10103000.00
ZKH income_statement (quarterly, 2026-03-31) — Net Interest Income: 6144000.00
ZKH income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 6144000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Net PPE: 314157000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 2837349000.00
ZKH income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -7325000.00
ZKH income_statement (quarterly, 2026-03-31) — Normalized Income: -10103000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Notes Receivable: 142929000.00
ZKH income_statement (quarterly, 2026-03-31) — Operating Income: -22497000.00
ZKH income_statement (quarterly, 2026-03-31) — Operating Revenue: 2102872000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 5574676062.00
ZKH balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 179508000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 2305000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -60860000.00
ZKH income_statement (quarterly, 2026-03-31) — Other Gand A: 131934000.00
ZKH income_statement (quarterly, 2026-03-31) — Other Income Expense: 6765000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 37583000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 34969000.00
ZKH income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 6765000.00
ZKH income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 77608000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Other Properties: 314157000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 710454000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Payables: 2487578000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 2877675000.00
ZKH income_statement (quarterly, 2026-03-31) — Pretax Income: -9588000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Receivables: 3221877000.00
ZKH income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1759792000.00
ZKH income_statement (quarterly, 2026-03-31) — Research And Development: 29342000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 50891000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -5327234000.00
ZKH income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 137640000.00
ZKH income_statement (quarterly, 2026-03-31) — Selling General And Administration: 269574000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Share Issued: 5693505340.00
ZKH balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 2905739000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 2837349000.00
ZKH income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
ZKH income_statement (quarterly, 2026-03-31) — Tax Provision: 515000.00
ZKH income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
ZKH balance_sheet (quarterly, 2026-03-31) — Total Assets: 6261474000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 2948390000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Total Debt: 405286000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 2905739000.00
ZKH income_statement (quarterly, 2026-03-31) — Total Expenses: 2136316000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 3355735000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 382547000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 160867000.00
ZKH income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -22497000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 118829278.00
ZKH balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 91435000.00
ZKH balance_sheet (quarterly, 2026-03-31) — Working Capital: 2684059000.00
ZKIN income_statement (annual, 2021-09-30) — Basic Average Shares: 3124799.00
ZKIN income_statement (annual, 2021-09-30) — Basic EPS: -1.19
ZKIN cash_flow (annual, 2021-09-30) — Change In Income Tax Payable: -77214.00
ZKIN cash_flow (annual, 2021-09-30) — Change In Tax Payable: -77214.00
ZKIN cash_flow (annual, 2021-09-30) — Common Stock Issuance: 24758458.00
ZKIN cash_flow (annual, 2021-09-30) — Deferred Income Tax: -511974.00
ZKIN cash_flow (annual, 2021-09-30) — Deferred Tax: -511974.00
ZKIN income_statement (annual, 2021-09-30) — Diluted Average Shares: 3233402.00
ZKIN income_statement (annual, 2021-09-30) — Diluted EPS: -1.19
ZKIN cash_flow (annual, 2021-09-30) — Gain Loss On Sale Of Business: 0.00
ZKIN cash_flow (annual, 2021-09-30) — Gain Loss On Sale Of PPE: 0.00
ZKIN income_statement (annual, 2021-09-30) — Gain On Sale Of Business: 0.00
ZKIN income_statement (annual, 2021-09-30) — Gain On Sale Of Security: 50649.00
ZKIN cash_flow (annual, 2021-09-30) — Issuance Of Capital Stock: 24758458.00
ZKIN cash_flow (annual, 2021-09-30) — Long Term Debt Issuance: 0.00
ZKIN cash_flow (annual, 2021-09-30) — Long Term Debt Payments: -483458.00
ZKIN cash_flow (annual, 2021-09-30) — Net Common Stock Issuance: 24758458.00
ZKIN cash_flow (annual, 2021-09-30) — Net Investment Purchase And Sale: -25000000.00
ZKIN cash_flow (annual, 2021-09-30) — Net Long Term Debt Issuance: -483458.00
ZKIN balance_sheet (annual, 2021-09-30) — Other Non Current Assets: 12472847.00
ZKIN cash_flow (annual, 2021-09-30) — Proceeds From Stock Option Exercised: 1345056.00
ZKIN cash_flow (annual, 2021-09-30) — Provisionand Write Offof Assets: 0.00
ZKIN cash_flow (annual, 2021-09-30) — Purchase Of Investment: -25000000.00
ZKIN cash_flow (annual, 2021-09-30) — Sale Of Intangibles: 0.00
ZKIN cash_flow (annual, 2021-09-30) — Sale Of PPE: 0.00
ZKIN income_statement (annual, 2022-09-30) — +Operating Expense: 8789190.00
ZKIN income_statement (annual, 2022-09-30) — +Total Revenue: 102391636.00
ZKIN balance_sheet (annual, 2022-09-30) — Accounts Payable: 10066758.00
ZKIN balance_sheet (annual, 2022-09-30) — Accounts Receivable: 28362933.00
ZKIN balance_sheet (annual, 2022-09-30) — Accumulated Depreciation: -6061550.00
ZKIN balance_sheet (annual, 2022-09-30) — Additional Paid In Capital: 70872765.00
ZKIN balance_sheet (annual, 2022-09-30) — Allowance For Doubtful Accounts Receivable: -255322.00
ZKIN cash_flow (annual, 2022-09-30) — Amortization Cash Flow: 830481.00
ZKIN cash_flow (annual, 2022-09-30) — Amortization Of Intangibles: 830481.00
ZKIN cash_flow (annual, 2022-09-30) — Asset Impairment Charge: 2998856.00
ZKIN income_statement (annual, 2022-09-30) — Basic Average Shares: 4186546.00
ZKIN income_statement (annual, 2022-09-30) — Basic EPS: -1.47
ZKIN cash_flow (annual, 2022-09-30) — Beginning Cash Position: 13603204.00
ZKIN balance_sheet (annual, 2022-09-30) — Buildings And Improvements: 5817029.00
ZKIN cash_flow (annual, 2022-09-30) — Capital Expenditure: -2108436.00
ZKIN balance_sheet (annual, 2022-09-30) — Capital Lease Obligations: 21010.00
ZKIN balance_sheet (annual, 2022-09-30) — Capital Stock: 0.00
ZKIN balance_sheet (annual, 2022-09-30) — Cash And Cash Equivalents: 7515147.00
ZKIN balance_sheet (annual, 2022-09-30) — Cash Cash Equivalents And Short Term Investments: 8430763.00
ZKIN cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Financing Activities: -969956.00
ZKIN cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Investing Activities: -2108436.00
ZKIN cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Operating Activities: -2072220.00
ZKIN cash_flow (annual, 2022-09-30) — Change In Account Payable: 8803924.00
ZKIN cash_flow (annual, 2022-09-30) — Change In Accrued Expense: 971419.00
ZKIN cash_flow (annual, 2022-09-30) — Change In Income Tax Payable: 0.00
ZKIN cash_flow (annual, 2022-09-30) — Change In Inventory: -2606504.00
ZKIN cash_flow (annual, 2022-09-30) — Change In Other Current Liabilities: 734391.00
ZKIN cash_flow (annual, 2022-09-30) — Change In Other Working Capital: -3662097.00
ZKIN cash_flow (annual, 2022-09-30) — Change In Payable: 8803924.00
ZKIN cash_flow (annual, 2022-09-30) — Change In Payables And Accrued Expense: 9775343.00
ZKIN cash_flow (annual, 2022-09-30) — Change In Prepaid Assets: 5493624.00
ZKIN cash_flow (annual, 2022-09-30) — Change In Receivables: -12374228.00
ZKIN cash_flow (annual, 2022-09-30) — Change In Tax Payable: 0.00
ZKIN cash_flow (annual, 2022-09-30) — Change In Working Capital: -2639471.00
ZKIN cash_flow (annual, 2022-09-30) — Changes In Account Receivables: -12059620.00
ZKIN cash_flow (annual, 2022-09-30) — Changes In Cash: -5150612.00
ZKIN balance_sheet (annual, 2022-09-30) — Common Stock: 0.00
ZKIN balance_sheet (annual, 2022-09-30) — Common Stock Equity: 84677705.00
ZKIN cash_flow (annual, 2022-09-30) — Common Stock Issuance: 0.00
ZKIN balance_sheet (annual, 2022-09-30) — Construction In Progress: 11668.00
ZKIN income_statement (annual, 2022-09-30) — Cost Of Revenue: 94796037.00
ZKIN balance_sheet (annual, 2022-09-30) — Current Accrued Expenses: 1880377.00
ZKIN balance_sheet (annual, 2022-09-30) — Current Assets: 66769931.00
ZKIN balance_sheet (annual, 2022-09-30) — Current Capital Lease Obligation: 10754.00
ZKIN balance_sheet (annual, 2022-09-30) — Current Debt: 20313020.00
ZKIN balance_sheet (annual, 2022-09-30) — Current Debt And Capital Lease Obligation: 20323774.00
ZKIN balance_sheet (annual, 2022-09-30) — Current Deferred Liabilities: 1758800.00
ZKIN balance_sheet (annual, 2022-09-30) — Current Deferred Revenue: 1758800.00
ZKIN balance_sheet (annual, 2022-09-30) — Current Liabilities: 43848943.00
ZKIN balance_sheet (annual, 2022-09-30) — Current Notes Payable: 702889.00
ZKIN cash_flow (annual, 2022-09-30) — Deferred Income Tax: -1428458.00
ZKIN cash_flow (annual, 2022-09-30) — Deferred Tax: -1428458.00
ZKIN cash_flow (annual, 2022-09-30) — Depreciation: 672368.00
ZKIN cash_flow (annual, 2022-09-30) — Depreciation Amortization Depletion: 1502849.00
ZKIN cash_flow (annual, 2022-09-30) — Depreciation And Amortization: 1502849.00
ZKIN income_statement (annual, 2022-09-30) — Diluted Average Shares: 4204540.00
ZKIN income_statement (annual, 2022-09-30) — Diluted EPS: -1.47
ZKIN income_statement (annual, 2022-09-30) — Diluted NI Availto Com Stockholders: -6081413.00
ZKIN balance_sheet (annual, 2022-09-30) — Dueto Related Parties Current: 2052403.00
ZKIN income_statement (annual, 2022-09-30) — EBIT: -3943445.00
ZKIN income_statement (annual, 2022-09-30) — EBITDA: -2440596.00
ZKIN cash_flow (annual, 2022-09-30) — Effect Of Exchange Rate Changes: -835453.00
ZKIN cash_flow (annual, 2022-09-30) — End Cash Position: 7617139.00
ZKIN cash_flow (annual, 2022-09-30) — Financing Cash Flow: -969956.00
ZKIN balance_sheet (annual, 2022-09-30) — Finished Goods: 7463030.00
ZKIN cash_flow (annual, 2022-09-30) — Free Cash Flow: -4180656.00
ZKIN cash_flow (annual, 2022-09-30) — Gain Loss On Sale Of Business: 0.00
ZKIN cash_flow (annual, 2022-09-30) — Gain Loss On Sale Of PPE: 0.00
ZKIN income_statement (annual, 2022-09-30) — Gain On Sale Of Business: 0.00
ZKIN balance_sheet (annual, 2022-09-30) — Gains Losses Not Affecting Retained Earnings: 535803.00
ZKIN income_statement (annual, 2022-09-30) — General And Administrative Expense: 5421575.00
ZKIN balance_sheet (annual, 2022-09-30) — Goodwill And Other Intangible Assets: 11415451.00
ZKIN balance_sheet (annual, 2022-09-30) — Gross Accounts Receivable: 28618255.00
ZKIN balance_sheet (annual, 2022-09-30) — Gross PPE: 13217135.00
ZKIN income_statement (annual, 2022-09-30) — Gross Profit: 7595599.00
ZKIN income_statement (annual, 2022-09-30) — Impairment Of Capital Assets: 2771019.00
ZKIN cash_flow (annual, 2022-09-30) — Income Tax Paid Supplemental Data: 87473.00
ZKIN balance_sheet (annual, 2022-09-30) — Income Tax Payable: 817059.00
ZKIN income_statement (annual, 2022-09-30) — Interest Expense: 3451665.00
ZKIN income_statement (annual, 2022-09-30) — Interest Expense Non Operating: 3451665.00
ZKIN income_statement (annual, 2022-09-30) — Interest Income: 109290.00
ZKIN income_statement (annual, 2022-09-30) — Interest Income Non Operating: 109290.00
ZKIN cash_flow (annual, 2022-09-30) — Interest Paid Supplemental Data: 976091.00
ZKIN balance_sheet (annual, 2022-09-30) — Inventories Adjustments Allowances: -102365.00
ZKIN balance_sheet (annual, 2022-09-30) — Inventory: 21141501.00
ZKIN balance_sheet (annual, 2022-09-30) — Invested Capital: 104990725.00
ZKIN cash_flow (annual, 2022-09-30) — Investing Cash Flow: -2108436.00
ZKIN balance_sheet (annual, 2022-09-30) — Investments And Advances: 25292866.00
ZKIN cash_flow (annual, 2022-09-30) — Issuance Of Capital Stock: 0.00
ZKIN cash_flow (annual, 2022-09-30) — Issuance Of Debt: 31113044.00
ZKIN balance_sheet (annual, 2022-09-30) — Line Of Credit: 16257820.00
ZKIN balance_sheet (annual, 2022-09-30) — Long Term Capital Lease Obligation: 10256.00
ZKIN balance_sheet (annual, 2022-09-30) — Long Term Debt And Capital Lease Obligation: 10256.00
ZKIN cash_flow (annual, 2022-09-30) — Long Term Debt Issuance: 0.00
ZKIN cash_flow (annual, 2022-09-30) — Long Term Debt Payments: -279004.00
ZKIN balance_sheet (annual, 2022-09-30) — Machinery Furniture Equipment: 7357440.00
ZKIN balance_sheet (annual, 2022-09-30) — Minority Interest: 386676.00
ZKIN income_statement (annual, 2022-09-30) — Minority Interests: -27147.00
ZKIN cash_flow (annual, 2022-09-30) — Net Business Purchase And Sale: 0.00
ZKIN cash_flow (annual, 2022-09-30) — Net Common Stock Issuance: 0.00
ZKIN balance_sheet (annual, 2022-09-30) — Net Debt: 12797873.00
ZKIN income_statement (annual, 2022-09-30) — Net Income: -6081413.00
ZKIN income_statement (annual, 2022-09-30) — Net Income Common Stockholders: -6081413.00
ZKIN income_statement (annual, 2022-09-30) — Net Income Continuous Operations: -6054266.00
ZKIN income_statement (annual, 2022-09-30) — Net Income From Continuing And Discontinued Operation: -6081413.00
ZKIN income_statement (annual, 2022-09-30) — Net Income From Continuing Operation Net Minority Interest: -6081413.00
ZKIN cash_flow (annual, 2022-09-30) — Net Income From Continuing Operations: -6054266.00
ZKIN income_statement (annual, 2022-09-30) — Net Income Including Noncontrolling Interests: -6054266.00
ZKIN cash_flow (annual, 2022-09-30) — Net Intangibles Purchase And Sale: -1588107.00
ZKIN income_statement (annual, 2022-09-30) — Net Interest Income: -3342375.00
ZKIN cash_flow (annual, 2022-09-30) — Net Investment Purchase And Sale: 0.00
ZKIN cash_flow (annual, 2022-09-30) — Net Issuance Payments Of Debt: -3667425.00
ZKIN cash_flow (annual, 2022-09-30) — Net Long Term Debt Issuance: -279004.00
ZKIN income_statement (annual, 2022-09-30) — Net Non Operating Interest Income Expense: -3342375.00
ZKIN cash_flow (annual, 2022-09-30) — Net Other Financing Charges: 2697469.00
ZKIN balance_sheet (annual, 2022-09-30) — Net PPE: 7155585.00
ZKIN cash_flow (annual, 2022-09-30) — Net PPE Purchase And Sale: -520329.00
ZKIN cash_flow (annual, 2022-09-30) — Net Short Term Debt Issuance: -3388421.00
ZKIN balance_sheet (annual, 2022-09-30) — Net Tangible Assets: 73262254.00
ZKIN balance_sheet (annual, 2022-09-30) — Non Current Accounts Receivable: 7522188.00
ZKIN balance_sheet (annual, 2022-09-30) — Non Current Deferred Assets: 320164.00
ZKIN balance_sheet (annual, 2022-09-30) — Non Current Deferred Taxes Assets: 320164.00
ZKIN balance_sheet (annual, 2022-09-30) — Non Current Prepaid Assets: 10447395.00
ZKIN income_statement (annual, 2022-09-30) — Normalized EBITDA: 330423.00
ZKIN income_statement (annual, 2022-09-30) — Normalized Income: -3812821.17
ZKIN balance_sheet (annual, 2022-09-30) — Notes Receivable: 49611.00
ZKIN cash_flow (annual, 2022-09-30) — Operating Cash Flow: -2072220.00
ZKIN income_statement (annual, 2022-09-30) — Operating Income: -1193591.00
ZKIN income_statement (annual, 2022-09-30) — Operating Revenue: 102391636.00
ZKIN balance_sheet (annual, 2022-09-30) — Ordinary Shares Number: 4341848.00
ZKIN balance_sheet (annual, 2022-09-30) — Other Current Borrowings: 3352311.00
ZKIN balance_sheet (annual, 2022-09-30) — Other Current Liabilities: 2802190.00
ZKIN balance_sheet (annual, 2022-09-30) — Other Equity Adjustments: 535803.00
ZKIN balance_sheet (annual, 2022-09-30) — Other Equity Interest: -125000.00
ZKIN income_statement (annual, 2022-09-30) — Other Gand A: 5421575.00
ZKIN income_statement (annual, 2022-09-30) — Other Income Expense: -2859144.00
ZKIN balance_sheet (annual, 2022-09-30) — Other Intangible Assets: 11415451.00
ZKIN cash_flow (annual, 2022-09-30) — Other Non Cash Items: 873463.00
ZKIN income_statement (annual, 2022-09-30) — Other Non Operating Income Expenses: -88125.00
ZKIN balance_sheet (annual, 2022-09-30) — Other Properties: 30998.00
ZKIN balance_sheet (annual, 2022-09-30) — Other Receivables: 2360539.00
ZKIN balance_sheet (annual, 2022-09-30) — Other Short Term Investments: 915616.00
ZKIN balance_sheet (annual, 2022-09-30) — Payables: 17083802.00
ZKIN balance_sheet (annual, 2022-09-30) — Payables And Accrued Expenses: 18964179.00
ZKIN balance_sheet (annual, 2022-09-30) — Prepaid Assets: 6322592.00
ZKIN income_statement (annual, 2022-09-30) — Pretax Income: -7395110.00
ZKIN cash_flow (annual, 2022-09-30) — Proceeds From Stock Option Exercised: 0.00
ZKIN cash_flow (annual, 2022-09-30) — Provisionand Write Offof Assets: 0.00
ZKIN cash_flow (annual, 2022-09-30) — Purchase Of Business: 0.00
ZKIN cash_flow (annual, 2022-09-30) — Purchase Of Intangibles: -1588107.00
ZKIN cash_flow (annual, 2022-09-30) — Purchase Of Investment: 0.00
ZKIN cash_flow (annual, 2022-09-30) — Purchase Of PPE: -520329.00
ZKIN balance_sheet (annual, 2022-09-30) — Raw Materials: 5609999.00
ZKIN balance_sheet (annual, 2022-09-30) — Receivables: 30773083.00
ZKIN income_statement (annual, 2022-09-30) — Reconciled Cost Of Revenue: 94796037.00
ZKIN income_statement (annual, 2022-09-30) — Reconciled Depreciation: 1502849.00
ZKIN cash_flow (annual, 2022-09-30) — Repayment Of Debt: -34780469.00
ZKIN income_statement (annual, 2022-09-30) — Research And Development: 987186.00
ZKIN balance_sheet (annual, 2022-09-30) — Restricted Cash: 101992.00
ZKIN balance_sheet (annual, 2022-09-30) — Retained Earnings: 13394137.00
ZKIN income_statement (annual, 2022-09-30) — Selling And Marketing Expense: 2380429.00
ZKIN income_statement (annual, 2022-09-30) — Selling General And Administration: 7802004.00
ZKIN balance_sheet (annual, 2022-09-30) — Share Issued: 4341848.00
ZKIN cash_flow (annual, 2022-09-30) — Short Term Debt Issuance: 31113044.00
ZKIN cash_flow (annual, 2022-09-30) — Short Term Debt Payments: -34501465.00
ZKIN income_statement (annual, 2022-09-30) — Special Income Charges: -2771019.00
ZKIN cash_flow (annual, 2022-09-30) — Stock Based Compensation: 2674807.00
ZKIN balance_sheet (annual, 2022-09-30) — Stockholders Equity: 84677705.00
ZKIN balance_sheet (annual, 2022-09-30) — Tangible Book Value: 73262254.00
ZKIN income_statement (annual, 2022-09-30) — Tax Effect Of Unusual Items: -502427.17
ZKIN income_statement (annual, 2022-09-30) — Tax Provision: -1340844.00
ZKIN income_statement (annual, 2022-09-30) — Tax Rate For Calcs: 0.18
ZKIN balance_sheet (annual, 2022-09-30) — Total Assets: 128923580.00
ZKIN balance_sheet (annual, 2022-09-30) — Total Capitalization: 84677705.00
ZKIN balance_sheet (annual, 2022-09-30) — Total Debt: 20334030.00
ZKIN balance_sheet (annual, 2022-09-30) — Total Equity Gross Minority Interest: 85064381.00
ZKIN income_statement (annual, 2022-09-30) — Total Expenses: 103585227.00
ZKIN balance_sheet (annual, 2022-09-30) — Total Liabilities Net Minority Interest: 43859199.00
ZKIN balance_sheet (annual, 2022-09-30) — Total Non Current Assets: 62153649.00
ZKIN balance_sheet (annual, 2022-09-30) — Total Non Current Liabilities Net Minority Interest: 10256.00
ZKIN income_statement (annual, 2022-09-30) — Total Operating Income As Reported: -3964610.00
ZKIN balance_sheet (annual, 2022-09-30) — Total Tax Payable: 4964641.00
ZKIN income_statement (annual, 2022-09-30) — Total Unusual Items: -2771019.00
ZKIN income_statement (annual, 2022-09-30) — Total Unusual Items Excluding Goodwill: -2771019.00
ZKIN balance_sheet (annual, 2022-09-30) — Work In Process: 8170837.00
ZKIN balance_sheet (annual, 2022-09-30) — Working Capital: 22920988.00
ZKIN income_statement (annual, 2023-09-30) — +Operating Expense: 8536487.00
ZKIN income_statement (annual, 2023-09-30) — +Total Revenue: 111599686.00
ZKIN balance_sheet (annual, 2023-09-30) — Accounts Payable: 2611220.00
ZKIN balance_sheet (annual, 2023-09-30) — Accounts Receivable: 14967186.00
ZKIN balance_sheet (annual, 2023-09-30) — Accumulated Depreciation: -6456179.00
ZKIN balance_sheet (annual, 2023-09-30) — Additional Paid In Capital: 72886898.00
ZKIN balance_sheet (annual, 2023-09-30) — Allowance For Doubtful Accounts Receivable: -6617485.00
ZKIN income_statement (annual, 2023-09-30) — Amortization: 298431.00
ZKIN cash_flow (annual, 2023-09-30) — Amortization Cash Flow: 298431.00
ZKIN cash_flow (annual, 2023-09-30) — Amortization Of Intangibles: 298431.00
ZKIN income_statement (annual, 2023-09-30) — Amortization Of Intangibles Income Statement: 298431.00
ZKIN cash_flow (annual, 2023-09-30) — Asset Impairment Charge: 53244103.00
ZKIN income_statement (annual, 2023-09-30) — Basic Average Shares: 4492280.00
ZKIN income_statement (annual, 2023-09-30) — Basic EPS: -10.76
ZKIN cash_flow (annual, 2023-09-30) — Beginning Cash Position: 7617139.00
ZKIN balance_sheet (annual, 2023-09-30) — Buildings And Improvements: 5687114.00
ZKIN cash_flow (annual, 2023-09-30) — Capital Expenditure: -2294462.00
ZKIN balance_sheet (annual, 2023-09-30) — Capital Lease Obligations: 33560.00
ZKIN balance_sheet (annual, 2023-09-30) — Capital Stock: 0.00
ZKIN balance_sheet (annual, 2023-09-30) — Cash And Cash Equivalents: 4994411.00
ZKIN balance_sheet (annual, 2023-09-30) — Cash Cash Equivalents And Short Term Investments: 5042556.00
ZKIN cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Financing Activities: 2068157.00
ZKIN cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Investing Activities: -2294462.00
ZKIN cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Operating Activities: -1905912.00
ZKIN cash_flow (annual, 2023-09-30) — Change In Account Payable: -7451608.00
ZKIN cash_flow (annual, 2023-09-30) — Change In Accrued Expense: -1788852.00
ZKIN cash_flow (annual, 2023-09-30) — Change In Income Tax Payable: 0.00
ZKIN cash_flow (annual, 2023-09-30) — Change In Inventory: 2870541.00
ZKIN cash_flow (annual, 2023-09-30) — Change In Other Current Liabilities: -690196.00
ZKIN cash_flow (annual, 2023-09-30) — Change In Other Working Capital: -923844.00
ZKIN cash_flow (annual, 2023-09-30) — Change In Payable: -7451608.00
ZKIN cash_flow (annual, 2023-09-30) — Change In Payables And Accrued Expense: -9240460.00
ZKIN cash_flow (annual, 2023-09-30) — Change In Prepaid Assets: 2108471.00
ZKIN cash_flow (annual, 2023-09-30) — Change In Receivables: 8508503.00
ZKIN cash_flow (annual, 2023-09-30) — Change In Tax Payable: 0.00
ZKIN cash_flow (annual, 2023-09-30) — Change In Working Capital: 2633015.00
ZKIN cash_flow (annual, 2023-09-30) — Changes In Account Receivables: 8165567.00
ZKIN cash_flow (annual, 2023-09-30) — Changes In Cash: -2132218.00
ZKIN balance_sheet (annual, 2023-09-30) — Common Stock: 0.00
ZKIN balance_sheet (annual, 2023-09-30) — Common Stock Equity: 25080812.00
ZKIN cash_flow (annual, 2023-09-30) — Common Stock Issuance: 0.00
ZKIN balance_sheet (annual, 2023-09-30) — Construction In Progress: 899850.00
ZKIN income_statement (annual, 2023-09-30) — Cost Of Revenue: 110303270.00
ZKIN balance_sheet (annual, 2023-09-30) — Current Accrued Expenses: 1918415.00
ZKIN balance_sheet (annual, 2023-09-30) — Current Assets: 43246444.00
ZKIN balance_sheet (annual, 2023-09-30) — Current Capital Lease Obligation: 21749.00
ZKIN balance_sheet (annual, 2023-09-30) — Current Debt: 13441048.00
ZKIN balance_sheet (annual, 2023-09-30) — Current Debt And Capital Lease Obligation: 13462797.00
ZKIN balance_sheet (annual, 2023-09-30) — Current Deferred Liabilities: 821694.00
ZKIN balance_sheet (annual, 2023-09-30) — Current Deferred Revenue: 821694.00
ZKIN balance_sheet (annual, 2023-09-30) — Current Liabilities: 24890689.00
ZKIN balance_sheet (annual, 2023-09-30) — Current Notes Payable: 41118.00
ZKIN cash_flow (annual, 2023-09-30) — Deferred Income Tax: -500443.00
ZKIN cash_flow (annual, 2023-09-30) — Deferred Tax: -500443.00
ZKIN cash_flow (annual, 2023-09-30) — Depreciation: 677275.00
ZKIN cash_flow (annual, 2023-09-30) — Depreciation Amortization Depletion: 975706.00
ZKIN income_statement (annual, 2023-09-30) — Depreciation Amortization Depletion Income Statement: 527449.00
ZKIN cash_flow (annual, 2023-09-30) — Depreciation And Amortization: 975706.00
ZKIN income_statement (annual, 2023-09-30) — Depreciation And Amortization In Income Statement: 527449.00
ZKIN income_statement (annual, 2023-09-30) — Depreciation Income Statement: 229018.00
ZKIN income_statement (annual, 2023-09-30) — Diluted Average Shares: 4492280.00
ZKIN income_statement (annual, 2023-09-30) — Diluted EPS: -10.76
ZKIN income_statement (annual, 2023-09-30) — Diluted NI Availto Com Stockholders: -61060794.00
ZKIN balance_sheet (annual, 2023-09-30) — Dueto Related Parties Current: 1111001.00
ZKIN income_statement (annual, 2023-09-30) — EBIT: -60166511.00
ZKIN income_statement (annual, 2023-09-30) — EBITDA: -59190805.00
ZKIN cash_flow (annual, 2023-09-30) — Effect Of Exchange Rate Changes: -439515.00
ZKIN cash_flow (annual, 2023-09-30) — End Cash Position: 5045406.00
ZKIN cash_flow (annual, 2023-09-30) — Financing Cash Flow: 2068157.00
ZKIN balance_sheet (annual, 2023-09-30) — Finished Goods: 7252583.00
ZKIN cash_flow (annual, 2023-09-30) — Free Cash Flow: -4200374.00
ZKIN balance_sheet (annual, 2023-09-30) — Gains Losses Not Affecting Retained Earnings: -14429.00
ZKIN income_statement (annual, 2023-09-30) — General And Administrative Expense: 5144340.00
ZKIN balance_sheet (annual, 2023-09-30) — Goodwill And Other Intangible Assets: 1437384.00
ZKIN balance_sheet (annual, 2023-09-30) — Gross Accounts Receivable: 21584671.00
ZKIN balance_sheet (annual, 2023-09-30) — Gross PPE: 14336036.00
ZKIN income_statement (annual, 2023-09-30) — Gross Profit: 1296416.00
ZKIN income_statement (annual, 2023-09-30) — Impairment Of Capital Assets: 53203517.00
ZKIN cash_flow (annual, 2023-09-30) — Income Tax Paid Supplemental Data: 38695.00
ZKIN balance_sheet (annual, 2023-09-30) — Income Tax Payable: 669.00
ZKIN income_statement (annual, 2023-09-30) — Interest Expense: 1583734.00
ZKIN income_statement (annual, 2023-09-30) — Interest Expense Non Operating: 1583734.00
ZKIN income_statement (annual, 2023-09-30) — Interest Income: 36699.00
ZKIN income_statement (annual, 2023-09-30) — Interest Income Non Operating: 36699.00
ZKIN cash_flow (annual, 2023-09-30) — Interest Paid Supplemental Data: 774929.00
ZKIN balance_sheet (annual, 2023-09-30) — Inventories Adjustments Allowances: 0.00
ZKIN balance_sheet (annual, 2023-09-30) — Inventory: 17937425.00
ZKIN balance_sheet (annual, 2023-09-30) — Invested Capital: 47049546.00
ZKIN cash_flow (annual, 2023-09-30) — Investing Cash Flow: -2294462.00
ZKIN balance_sheet (annual, 2023-09-30) — Investments And Advances: 285540.00
ZKIN cash_flow (annual, 2023-09-30) — Issuance Of Capital Stock: 0.00
ZKIN cash_flow (annual, 2023-09-30) — Issuance Of Debt: 21486396.00
ZKIN balance_sheet (annual, 2023-09-30) — Line Of Credit: 9388706.00
ZKIN balance_sheet (annual, 2023-09-30) — Long Term Capital Lease Obligation: 11811.00
ZKIN balance_sheet (annual, 2023-09-30) — Long Term Debt: 8527686.00
ZKIN balance_sheet (annual, 2023-09-30) — Long Term Debt And Capital Lease Obligation: 8539497.00
ZKIN cash_flow (annual, 2023-09-30) — Long Term Debt Payments: 0.00
ZKIN balance_sheet (annual, 2023-09-30) — Machinery Furniture Equipment: 7705232.00
ZKIN balance_sheet (annual, 2023-09-30) — Minority Interest: 157980.00
ZKIN income_statement (annual, 2023-09-30) — Minority Interests: 229596.00
ZKIN cash_flow (annual, 2023-09-30) — Net Business Purchase And Sale: 0.00
ZKIN cash_flow (annual, 2023-09-30) — Net Common Stock Issuance: 0.00
ZKIN balance_sheet (annual, 2023-09-30) — Net Debt: 16974323.00
ZKIN income_statement (annual, 2023-09-30) — Net Income: -61060794.00
ZKIN income_statement (annual, 2023-09-30) — Net Income Common Stockholders: -61060794.00
ZKIN income_statement (annual, 2023-09-30) — Net Income Continuous Operations: -61290390.00
ZKIN income_statement (annual, 2023-09-30) — Net Income From Continuing And Discontinued Operation: -61060794.00
ZKIN income_statement (annual, 2023-09-30) — Net Income From Continuing Operation Net Minority Interest: -61060794.00
ZKIN cash_flow (annual, 2023-09-30) — Net Income From Continuing Operations: -61290390.00
ZKIN income_statement (annual, 2023-09-30) — Net Income Including Noncontrolling Interests: -61290390.00
ZKIN cash_flow (annual, 2023-09-30) — Net Intangibles Purchase And Sale: -707470.00
ZKIN income_statement (annual, 2023-09-30) — Net Interest Income: -1547035.00
ZKIN cash_flow (annual, 2023-09-30) — Net Investment Purchase And Sale: 0.00
ZKIN cash_flow (annual, 2023-09-30) — Net Issuance Payments Of Debt: 2136305.00
ZKIN cash_flow (annual, 2023-09-30) — Net Long Term Debt Issuance: 0.00
ZKIN income_statement (annual, 2023-09-30) — Net Non Operating Interest Income Expense: -1547035.00
ZKIN cash_flow (annual, 2023-09-30) — Net Other Financing Charges: -68148.00
ZKIN balance_sheet (annual, 2023-09-30) — Net PPE: 7879857.00
ZKIN cash_flow (annual, 2023-09-30) — Net PPE Purchase And Sale: -1586992.00
ZKIN cash_flow (annual, 2023-09-30) — Net Short Term Debt Issuance: 2136305.00
ZKIN balance_sheet (annual, 2023-09-30) — Net Tangible Assets: 23643428.00
ZKIN balance_sheet (annual, 2023-09-30) — Non Current Accounts Receivable: 5527682.00
ZKIN balance_sheet (annual, 2023-09-30) — Non Current Deferred Assets: 0.00
ZKIN balance_sheet (annual, 2023-09-30) — Non Current Deferred Taxes Assets: 0.00
ZKIN balance_sheet (annual, 2023-09-30) — Non Current Prepaid Assets: 292070.00
ZKIN income_statement (annual, 2023-09-30) — Normalized EBITDA: -5987288.00
ZKIN income_statement (annual, 2023-09-30) — Normalized Income: -8253484.39
ZKIN balance_sheet (annual, 2023-09-30) — Notes Receivable: 54825.00
ZKIN cash_flow (annual, 2023-09-30) — Operating Cash Flow: -1905912.00
ZKIN income_statement (annual, 2023-09-30) — Operating Income: -7240071.00
ZKIN income_statement (annual, 2023-09-30) — Operating Revenue: 111599686.00
ZKIN balance_sheet (annual, 2023-09-30) — Ordinary Shares Number: 4713248.00
ZKIN balance_sheet (annual, 2023-09-30) — Other Current Borrowings: 4011224.00
ZKIN balance_sheet (annual, 2023-09-30) — Other Current Liabilities: 1758571.00
ZKIN balance_sheet (annual, 2023-09-30) — Other Equity Adjustments: -14429.00
ZKIN balance_sheet (annual, 2023-09-30) — Other Equity Interest: -125000.00
ZKIN income_statement (annual, 2023-09-30) — Other Gand A: 5144340.00
ZKIN income_statement (annual, 2023-09-30) — Other Income Expense: -52963139.00
ZKIN balance_sheet (annual, 2023-09-30) — Other Intangible Assets: 1437384.00
ZKIN cash_flow (annual, 2023-09-30) — Other Non Cash Items: 1017964.00
ZKIN balance_sheet (annual, 2023-09-30) — Other Non Current Liabilities: -1.00
ZKIN income_statement (annual, 2023-09-30) — Other Non Operating Income Expenses: 240378.00
ZKIN balance_sheet (annual, 2023-09-30) — Other Properties: 43840.00
ZKIN balance_sheet (annual, 2023-09-30) — Other Receivables: 383413.00
ZKIN balance_sheet (annual, 2023-09-30) — Other Short Term Investments: 48145.00
ZKIN income_statement (annual, 2023-09-30) — Other Taxes: 168962.00
ZKIN balance_sheet (annual, 2023-09-30) — Payables: 6929212.00
ZKIN balance_sheet (annual, 2023-09-30) — Payables And Accrued Expenses: 8847627.00
ZKIN balance_sheet (annual, 2023-09-30) — Prepaid Assets: 4810044.00
ZKIN income_statement (annual, 2023-09-30) — Pretax Income: -61750245.00
ZKIN cash_flow (annual, 2023-09-30) — Proceeds From Stock Option Exercised: 0.00
ZKIN cash_flow (annual, 2023-09-30) — Purchase Of Business: 0.00
ZKIN cash_flow (annual, 2023-09-30) — Purchase Of Intangibles: -707470.00
ZKIN cash_flow (annual, 2023-09-30) — Purchase Of Investment: 0.00
ZKIN cash_flow (annual, 2023-09-30) — Purchase Of PPE: -1586992.00
ZKIN balance_sheet (annual, 2023-09-30) — Raw Materials: 4551761.00
ZKIN balance_sheet (annual, 2023-09-30) — Receivables: 15405424.00
ZKIN income_statement (annual, 2023-09-30) — Reconciled Cost Of Revenue: 110303270.00
ZKIN income_statement (annual, 2023-09-30) — Reconciled Depreciation: 975706.00
ZKIN cash_flow (annual, 2023-09-30) — Repayment Of Debt: -19350091.00
ZKIN income_statement (annual, 2023-09-30) — Research And Development: 1274337.00
ZKIN balance_sheet (annual, 2023-09-30) — Restricted Cash: 50995.00
ZKIN balance_sheet (annual, 2023-09-30) — Retained Earnings: -47666657.00